|
(Last updated: 05 Feb 2008)
Trends and opportunities
The market
Healthcare in the UK is dominated by the state-run NHS, one of the largest organisations in Europe. The costs for UK healthcare provision is as follows:
- National Health Service (NHS) free of charge – A$190 billion
- private – A$34 billion
- complementary – A$1.5 billion
- palliative (mostly charities) – A$0.8 billion
(Various sources, including Key Note and NHS)
A NHS Institute of Innovation & Improvement was launched on 1 July 2005. The Institute will encourage modernisation, innovation and learning in the NHS. It will also help companies bring useful, new products to market and encourage their uptake by the NHS and social care services, leading to increased purchasing of beneficial new healthcare products, treatments and procedures.
A section of the Institute called the National Innovation Centre (NIC) will focus on linking companies with appropriate partners – for example in clinical practice, academia or finance. They will provide practical advice on how best to get innovative medical technologies and products taken up by the NHS.
The NIC will be based with the NHS Institute, on the campus of the University of Warwick but will operate as a network to benefit from the expertise that exists around the country.
The British Government has encouraged the private sector to become involved in the building and management of hospitals, something that is opposed by the main unions. There are also many companies involved in consulting to the NHS.
Due to the cost of providing healthcare on the NHS, the UK has a policy of encouraging self-medication. This is clearly demonstrated by NHS Direct, a telephone advice service staffed by qualified personnel. At the same time, people are becoming more aware of the benefits of healthy living and are looking towards preventative and complementary approaches.
Medical devices are classified as any product that is used for the diagnosis, monitoring, prevention or treatment of an illness or handicap. Australian companies have been successful in supplying surgical instruments and clinical devices to the NHS.
The UK market for medicines is split into prescription-only - POM (A$16 million) or non-prescription over-the-counter products (A$11 billion).
The British Government has set up the National Institute for Clinical Excellence (NICE), to decide which costly medicines to use in the NHS. At the same time, more products are being released from POM to General Sales List status so they can be bought without prescription.
Opportunities
Australian companies have already been successful in the UK with software and medical devices, but there are broader opportunities. Considering the cost of transport and competition from third countries, the main opportunities for Australia are in high value-add products:
- surgical instruments
- licensed medicines
- teaching aids
- hospital fittings and fixtures
The NHS is going through a period of unprecedented change. There are opportunities in the service areas of:
- administrative management of hospitals and clinics
- provision of care services for the elderly
- restructuring of healthcare services
- development of new facilities
- provision of online services
These areas cut across many industries, including ICT, clinical services, construction and education. The key is improved treatments for patients and improved cost-effectiveness and efficiency in the delivery of healthcare. |